Robert C. Young When I was growing up, my whole generation was haunted by the fear of polio. We all knew people who suffered from this disease and died, or were confined to iron lungs. But a vaccine changed the course of medical history and made polio a preventable disease. Likewise with cancer, the future of research rests not with making the equivalent of a better iron lung, but instead with the development of scientific strategies to prevent the disease. Despite dramatic advances in our
 Robert C. Young |
Despite dramatic advances in our scientific understanding of cancer and substantial improvements in our ability to treat it medically, cancer continues to exact a devastating personal and financial toll on society. Approximately 8.4 million Americans alive today have a history of cancer. This year alone in the United States, cancer will strike 1,220,100 people and will claim more than 552,000 lives--more than 1,500 people a day.
Researchers have long hoped ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
Learn practical strategies for optimizing sample preparation, fragmentation, library construction, and quality control to generate high-quality next-generation sequencing (NGS) data across a range of sample types.
Learn how bulk T-cell receptor (TCR) repertoire sequencing can reveal clonotype diversity, support immune monitoring, and generate biological insights for translational immunology and biomarker discovery.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
The Stirling Ultracold VAULT100™ PRO redefines ultra-low temperature storage with reliable -100°C performance, faster recovery, lower operating costs and sustainable operation. Learn how you can protect critical samples without compromise.
